These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 29861624

  • 41. Amino acid derivatives of ligustrazine-oleanolic acid as new cytotoxic agents.
    Chu F, Xu X, Li G, Gu S, Xu K, Gong Y, Xu B, Wang M, Zhang H, Zhang Y, Wang P, Lei H.
    Molecules; 2014 Nov 07; 19(11):18215-31. PubMed ID: 25387350
    [Abstract] [Full Text] [Related]

  • 42. Synthesis, Characterization and Anti-hepatoma Activity of New Hederagenin Derivatives.
    Liu X, Sun L, Liu QH, Chen BQ, Liu YM.
    Mini Rev Med Chem; 2020 Nov 07; 20(3):252-257. PubMed ID: 32134368
    [Abstract] [Full Text] [Related]

  • 43. An Approach to Treatment of Liver Cancer by Novel Glycyrrhizin Derivative.
    El-Senduny FF, Zidane MM, Youssef MM, Badria FA.
    Anticancer Agents Med Chem; 2019 Nov 07; 19(15):1863-1873. PubMed ID: 30973113
    [Abstract] [Full Text] [Related]

  • 44. Glycyrrhetinic Acid and TAT Peptide Modified Dual-functional Liposomes for Treatment of Hepatocellular Cancer.
    Huang S, Ren D, Wu X, Li M, Yu X, Nie X, Wang Y, Wang Y.
    Curr Top Med Chem; 2020 Nov 07; 20(27):2493-2505. PubMed ID: 32703132
    [Abstract] [Full Text] [Related]

  • 45. Design, synthesis and cytotoxic activity of N-Modified oleanolic saponins bearing A glucosamine.
    Lin YY, Chan SH, Juang YP, Hsiao HM, Guh JH, Liang PH.
    Eur J Med Chem; 2018 Jan 01; 143():1942-1958. PubMed ID: 29133061
    [Abstract] [Full Text] [Related]

  • 46. Design, synthesis, and structure-activity relationship study of glycyrrhetinic acid derivatives as potent and selective inhibitors against human carboxylesterase 2.
    Zou LW, Li YG, Wang P, Zhou K, Hou J, Jin Q, Hao DC, Ge GB, Yang L.
    Eur J Med Chem; 2016 Apr 13; 112():280-288. PubMed ID: 26900660
    [Abstract] [Full Text] [Related]

  • 47. Synthesis and cytotoxic activity of the N-acetylglucosamine-bearing triterpenoid saponins.
    Wang P, Wang J, Guo T, Li Y.
    Carbohydr Res; 2010 Mar 30; 345(5):607-20. PubMed ID: 20116049
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Synthesis of novel heterocyclic oleanolic acid derivatives with improved antiproliferative activity in solid tumor cells.
    Leal AS, Wang R, Salvador JA, Jing Y.
    Org Biomol Chem; 2013 Feb 13; 11(10):1726-38. PubMed ID: 23381885
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Involvement of BID translocation in glycyrrhetinic acid and 11-deoxy glycyrrhetinic acid-induced attenuation of gastric cancer growth.
    Lin D, Zhong W, Li J, Zhang B, Song G, Hu T.
    Nutr Cancer; 2014 Feb 13; 66(3):463-73. PubMed ID: 24547973
    [Abstract] [Full Text] [Related]

  • 52. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
    Farghaly AM, AboulWafa OM, Baghdadi HH, Abd El Razik HA, Sedra SMY, Shamaa MM.
    Bioorg Chem; 2021 Oct 13; 115():105208. PubMed ID: 34365057
    [Abstract] [Full Text] [Related]

  • 53. A library of 1,2,3-triazole-substituted oleanolic acid derivatives as anticancer agents: design, synthesis, and biological evaluation.
    Wei G, Luan W, Wang S, Cui S, Li F, Liu Y, Liu Y, Cheng M.
    Org Biomol Chem; 2015 Feb 07; 13(5):1507-14. PubMed ID: 25476168
    [Abstract] [Full Text] [Related]

  • 54. Discovery of an Oleanolic Acid/Hederagenin-Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer.
    Chen Z, Huang KY, Ling Y, Goto M, Duan HQ, Tong XH, Liu YL, Cheng YY, Morris-Natschke SL, Yang PC, Yang SL, Lee KH.
    J Nat Prod; 2019 Nov 22; 82(11):3065-3073. PubMed ID: 31718182
    [Abstract] [Full Text] [Related]

  • 55. Segetoside I, a plant-derived bisdesmosidic saponin, induces apoptosis in human hepatoma cells in vitro and inhibits tumor growth in vivo.
    Firempong CK, Zhang HY, Wang Y, Chen J, Cao X, Deng W, Zhou J, Wang Q, Tong SS, Yu J, Xu X.
    Pharmacol Res; 2016 Aug 22; 110():101-110. PubMed ID: 27180010
    [Abstract] [Full Text] [Related]

  • 56. QSAR and docking based semi-synthesis and in vitro evaluation of 18 β-glycyrrhetinic acid derivatives against human lung cancer cell line A-549.
    Yadav DK, Kalani K, Khan F, Srivastava SK.
    Med Chem; 2013 Dec 22; 9(8):1073-84. PubMed ID: 23675978
    [Abstract] [Full Text] [Related]

  • 57. Oleanane-type triterpenoid saponins from Lysimachia fortunei Maxim.
    Zhang SL, Yang ZN, He C, Liao HB, Wang HS, Chen ZF, Liang D.
    Phytochemistry; 2018 Mar 22; 147():140-146. PubMed ID: 29324278
    [Abstract] [Full Text] [Related]

  • 58. Conjugation of Uridine with Oleanolic Acid Derivatives as Potential Antitumor Agents.
    Cheng KG, Su CH, Huang JY, Liu J, Zheng YT, Chen ZF.
    Chem Biol Drug Des; 2016 Sep 22; 88(3):329-40. PubMed ID: 26990000
    [Abstract] [Full Text] [Related]

  • 59. Synthesis of an anthraquinone derivative (DHAQC) and its effect on induction of G2/M arrest and apoptosis in breast cancer MCF-7 cell line.
    Yeap S, Akhtar MN, Lim KL, Abu N, Ho WY, Zareen S, Roohani K, Ky H, Tan SW, Lajis N, Alitheen NB.
    Drug Des Devel Ther; 2015 Sep 22; 9():983-92. PubMed ID: 25733816
    [Abstract] [Full Text] [Related]

  • 60. Design and synthesis of novel mitochondria-targeted CDDO derivatives as potential anti-cancer agents.
    Ju W, Li N, Wang J, Yu N, Lei Z, Zhang L, Sun J, Chen L.
    Bioorg Chem; 2021 Oct 22; 115():105249. PubMed ID: 34390971
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.